Want to join the conversation?
$CRM 2Q16 PR: For 3Q16, revenue is projected to be approx. $1.69Bil to $1.7Bil, an increase of 22% to 23% YoverY. GAAP loss per share is expected to be in the range of $0.02 to $0.01. For FY16, revenue is projected to be approx. $6.6Bil to $6.625Bil, an increase of 23% YoverY. GAAP loss per share is expected to be in the range of $0.17 to $0.15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?